populations from tumor whole-genome sequence data TITAN : inference of copy number architectures in clonal cell Material Supplemental

Material Supplemental http://genome.cshlp.org/content/suppl/2014/08/28/gr.180281.114.DC1.html References http://genome.cshlp.org/content/24/11/1881.full.html#ref-list-1 This article cites 37 articles, 11 of which can be accessed free at: Open Access Open Access option. Genome Research Freely available online through the License Commons Creative . http://creativecommons.org/licenses/by/4.0 License (Attribution 4.0 International), as described at , is available under a Creative Commons Genome Research This article, published in

[1]  Nicholas B. Larson,et al.  PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data , 2013, Bioinform..

[2]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[3]  P. Maxwell,et al.  Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival. , 2012, Cancer research.

[4]  Michalis Vazirgiannis,et al.  Clustering validity checking methods: part II , 2002, SGMD.

[5]  A. Ashworth,et al.  The DNA damage response and cancer therapy , 2012, Nature.

[6]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[7]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[8]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[9]  P. A. Futreal,et al.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.

[10]  Irmtraud M. Meyer,et al.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.

[11]  Carlos Caldas,et al.  Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary , 2010, The Journal of pathology.

[12]  Christopher Yau,et al.  OncoSNP-SEQ: a statistical approach for the identification of somatic copy number alterations from next-generation sequencing of cancer genomes , 2013, Bioinform..

[13]  Carlos Caldas,et al.  The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.

[14]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[15]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[16]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[17]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[18]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[19]  J. Salk.  Clonal evolution in cancer , 2010 .

[20]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[21]  P. Campbell,et al.  Single-cell mutational profiling and clonal phylogeny in cancer , 2013, Genome research.

[22]  Tatiana Popova,et al.  Supplementary Methods , 2012, Acta Neuropsychiatrica.

[23]  Ali Bashashati,et al.  Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling , 2013, The Journal of pathology.

[24]  A. McKenna,et al.  Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.

[25]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[26]  Lovelace J. Luquette,et al.  Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes , 2013, Cell.

[27]  Mark D. Johnson,et al.  Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion , 2011, Proceedings of the National Academy of Sciences.

[28]  Joshua F. McMichael,et al.  Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.

[29]  John Quackenbush,et al.  Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome , 2012, Clinical Cancer Research.

[30]  Oliver Sieber,et al.  A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data , 2010, Genome Biology.

[31]  Benjamin J. Raphael,et al.  THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data , 2013, Genome Biology.

[32]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[33]  A. Bashashati,et al.  Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer , 2012, Genome research.

[34]  Christopher J. R. Illingworth,et al.  High-Definition Reconstruction of Clonal Composition in Cancer , 2014, Cell reports.

[35]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[36]  M. Gerstung,et al.  Reliable detection of subclonal single-nucleotide variants in tumour cell populations , 2012, Nature Communications.

[37]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .